Sigyn Therapeutics, Inc. (SIGY): Shares Outstanding

Annual figures by period end, from SEC filings.

Not updated since 2024-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

Stock splits: 1-for-40, first reflected in a filing dated 2024-02-20. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

1.61M

As of 2024-12-31

1.61M

As of 2025-09-30

2014-12-31 Shares Outstanding (shares) 2024-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period ended	Shares Outstanding	Change YoY	Source filing
2024-12-31	1.61M	+24.6%	2025-04-15, Balance as of period end
2023-12-31	1.29M	+34.7%	2025-04-15, Balance as of period end
2022-12-31	956.6K	n/c	2024-02-20, Balance as of period end
2021-12-31	37.30M	+5.9%	2023-03-31, Balance as of period end
2020-12-31	35.20M	-56.7%	2022-03-21, Balance as of period end
2019-12-31	81.27M	0.0%	2020-03-30, Balance as of period end
2018-12-31	81.27M	n/c	2020-03-30, Balance as of period end
2017-12-31	53.28M	n/c	2019-04-01, Balance as of period end
No annual figure between 2015-12-31 and 2017-12-31.
2015-12-31	34.32M	+15.0%	2016-03-30, Balance as of period end
2014-12-31	29.86M	n/a	2016-03-30, Balance as of period end